Coherus Oncology, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
C/O DENNIS M. LANFEAR, REDWOOD CITY, CA, 94065
Mailing Address
C/O DENNIS M. LANFEAR, REDWOOD CITY, CA, 94065
Phone
(650) 649-3530
Fiscal Year End
1231
EIN
273615821
Financial Overview
FY2025
-$193.43M
Stockholders' Equity
$1.43
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| 10-K Annual financial report | March 9, 2026 | View on SEC |
| 8-K Current report of material events | February 17, 2026 | View on SEC |
| 424B5 Prospectus supplement | February 13, 2026 | View on SEC |
| 424B5 Prospectus supplement | February 12, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 5, 2026 | View on SEC |
| 8-K Current report of material events | February 4, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 30, 2026 | View on SEC |
| 4 Insider stock transaction report | January 26, 2026 | View on SEC |
Annual Reports
10-K
March 9, 2026
- Coherus has strategically transformed into an oncology-focused biopharmaceutical company, divesting non-core assets.
- The company generates revenue from key oncology products like Loqtorzi and manages typical biopharma expenses.
Related Companies
Companies in the same industry (SIC: 2836)
MESOBLAST LTD
MESO
Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Scilex Holding Co
SCLX
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.